Companies / Avalyn Pharma Inc.

Avalyn Pharma Inc.

Nasdaq: AVLNCIK 1540171BOSTON, MA

Ownership

44.3M shares outstanding · as of Aug 31, 2026
8.8%10%+ / strategic
Ownership
10%+ / strategic8.76%3,883,289
Institutions7.36%3,264,665
Public float83.88%37,185,141

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Novo Holdings A/S10% owner
8.76%3,883,289

Institutional holders 4

View all →
HolderValue% of shares
NVP Associates, LLC$74.68M5.12%
BlackRock, Inc.$32.17M2.20%
Deutsche Bank AG$557.4K0.04%
Persistent Asset Partners Ltd$67.9K<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 1, 2026Novo Holdings A/S
10% owner
BuyVoting Common Stock$10.00M+556K
+16.69%
3,883,289
8.76% of shares
high
May 1, 2026Novo Holdings A/S
10% owner
OtherSeries D Preferred Stock—-12.6M
-100.00%
0
0.00% of shares
low
May 1, 2026Novo Holdings A/S
10% owner
OtherSeries C-2 Preferred Stock—-5.6M
-100.00%
0
0.00% of shares
low
May 1, 2026Novo Holdings A/S
10% owner
OtherSeries C-1 Preferred Stock—-25.9M
-100.00%
0
0.00% of shares
low
May 1, 2026Novo Holdings A/S
10% owner
OtherSeries B Preferred Stock—-2.0M
-100.00%
0
0.00% of shares
low
May 1, 2026Novo Holdings A/S
10% owner
OtherSeries A Preferred Stock—-18.0M
-100.00%
0
0.00% of shares
low
May 1, 2026Novo Holdings A/S
10% owner
OtherVoting Common Stock—+3.3M
3,327,734
7.51% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Perceptive Advisors LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AVLN——05348Y105—